Eisai Co Ltd Updates on Business Developments
Eisai Co Ltd has made several notable announcements regarding its business activities. The company has acquired EcoNaviSta, a partner in its dementia ecosystem, as part of its efforts to expand its presence in the field of neurodegenerative diseases.
Key Acquisition Details
- Eisai Co Ltd has acquired EcoNaviSta, a partner in its dementia ecosystem.
- This acquisition is part of Eisai’s strategy to expand its presence in neurodegenerative diseases.
GHIT Fund Investment
Separately, the Global Health Innovative Technology (GHIT) Fund has invested approximately USD 11.4 million in projects related to schistosomiasis diagnostics and research and development for neglected tropical diseases. This investment is expected to support the development of new treatments for these diseases.
Partners Involved in GHIT Fund Investment
- Drugs & Diagnostics for Tropical Diseases
- Medical & Biological Laboratories
- Eisai Co Ltd is not directly involved in this investment, but its partners are part of the project.